Prostate Cancer Clinical Trials in Chicago

Showing 81-100 of 202 trials

ACTIVE_NOT_RECRUITINGEARLY_PHASE12.2 miles

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

NCT03392181

The purpose of this study is to gain understanding of how PET-MR (positron emission tomography-magnetic resonance imaging) using the substance 18F-DCFPyL (PyL) may help in diagnosing prostate cancer and in determining the stage of prostate cancer before surgery.

Prostate Cancer

Northwestern University48 participantsStarted Jun 2018

Chicago, Illinois, United States

RECRUITINGNA2.2 miles

Clinical Trial of Approaches to Prostate Cancer Surgery

NCT05155501

This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.

Prostate Cancer

Weill Medical College of Cornell University600 participantsStarted May 2023

Washington D.C., District of Columbia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +2 more locations

RECRUITINGPHASE1/PHASE22.2 miles

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

NCT04104776

The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas.

Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more

Novartis Pharmaceuticals275 participantsStarted Sep 2019

Atlanta, Georgia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +57 more locations

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Clinical Trial of Approaches to Prostate Cancer Surgery

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Prostate Cancer Trials in Other Cities

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

MGD019 DART® Protein in Unresectable/Metastatic Cancer

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

Other Conditions in Chicago